147 related articles for article (PubMed ID: 35870629)
21. Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model.
Nagel G; Sousa-Herves A; Wedepohl S; Calderón M
Theranostics; 2020; 10(1):91-108. PubMed ID: 31903108
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment responsive nanogels as a smart triggered release platform for enhanced intracellular delivery of doxorubicin.
Kumar P; Behl G; Kaur S; Yadav N; Liu B; Chhikara A
J Biomater Sci Polym Ed; 2021 Feb; 32(3):385-404. PubMed ID: 33054642
[TBL] [Abstract][Full Text] [Related]
23. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
24. TPGS-functionalized and ortho ester-crosslinked dextran nanogels for enhanced cytotoxicity on multidrug resistant tumor cells.
Sun M; Wang X; Cheng X; He L; Yan G; Tang R
Carbohydr Polym; 2018 Oct; 198():142-154. PubMed ID: 30092984
[TBL] [Abstract][Full Text] [Related]
25. Dual responsive magnetic composite nanogels for thermo-chemotherapy.
Indulekha S; Arunkumar P; Bahadur D; Srivastava R
Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900
[TBL] [Abstract][Full Text] [Related]
26. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
27. A chitosan-modified graphene nanogel for noninvasive controlled drug release.
Wang C; Mallela J; Garapati US; Ravi S; Chinnasamy V; Girard Y; Howell M; Mohapatra S
Nanomedicine; 2013 Oct; 9(7):903-11. PubMed ID: 23352802
[TBL] [Abstract][Full Text] [Related]
28. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B
J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025
[TBL] [Abstract][Full Text] [Related]
29. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs.
Montero N; Pérez E; Benito M; Teijón C; Teijón JM; Olmo R; Blanco MD
Int J Pharm; 2019 Jan; 554():337-351. PubMed ID: 30439492
[TBL] [Abstract][Full Text] [Related]
30. Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream.
Kang JW; Cho HJ; Lee HJ; Jin HE; Maeng HJ
Int J Biol Macromol; 2019 Mar; 125():61-71. PubMed ID: 30521919
[TBL] [Abstract][Full Text] [Related]
31. In situ forming alginate/gelatin hybrid hydrogels containing doxorubicin loaded chitosan/AuNPs nanogels for the local therapy of breast cancer.
Alioghli Ziaei A; Erfan-Niya H; Fathi M; Amiryaghoubi N
Int J Biol Macromol; 2023 Aug; 246():125640. PubMed ID: 37394211
[TBL] [Abstract][Full Text] [Related]
32. ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin.
Obireddy SR; Lai WF
Int J Nanomedicine; 2022; 17():589-601. PubMed ID: 35173432
[TBL] [Abstract][Full Text] [Related]
33. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
34. Acid-degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro.
Zha Q; Wang X; Cheng X; Fu S; Yang G; Yao W; Tang R
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():246-257. PubMed ID: 28575982
[TBL] [Abstract][Full Text] [Related]
35. Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.
Qiao F; Jiang Z; Fang W; Sun J; Hu Q
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806347
[TBL] [Abstract][Full Text] [Related]
36. Characterizing poly(epsilon-caprolactone)-b-chitooligosaccharide-b-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups.
Chung TW; Liu DZ; Hsieh JH; Fan XC; Yang JD; Chen JH
J Nanosci Nanotechnol; 2006; 6(9-10):2902-11. PubMed ID: 17048497
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable phosphorylcholine-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells.
Peng S; Men Y; Xie R; Tian Y; Yang W
J Colloid Interface Sci; 2019 Mar; 539():19-29. PubMed ID: 30572286
[TBL] [Abstract][Full Text] [Related]
38. Improvement of the Antioxidant and Antitumor Activities of Benzimidazole-Chitosan Quaternary Ammonium Salt on Drug Delivery Nanogels.
Ma B; Li Q; Zhang J; Mi Y; Tan W; Guo Z
Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38248665
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin Intracellular Release
El Founi M; Laroui H; Canup BSB; Ametepe JS; Vanderesse R; Acherar S; Babin J; Ferji K; Chevalot I; Six JL
ACS Appl Bio Mater; 2021 Mar; 4(3):2742-2751. PubMed ID: 35014313
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
